Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cynthia Sprenger

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
European Urology|January 8, 2018
Androgen Receptor Variants and Castration-resistant Prostate Cancer: Looking Back and Looking ForwardTakuma Uo, Cynthia Sprenger
Cell Reports. Medicine|March 4, 2022
Starving lethal prostate cancer by targeting heat shock proteins and glycolytic enzymesStephen R Plymate, Cynthia Sprenger, Michael C Haffner
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Intracrine androgen biosynthesis and drug resistanceTrevor M Penning, Irfan A Asangani, Cynthia Sprenger, et al.
Vitamins and Hormones|September 17, 2023
The androgen receptorGreg Van-Duyne, Ian A Blair, Cynthia Sprenger, et al.
Oncotarget|December 8, 2014
MED1 mediates androgen receptor splice variant induced gene expression in the absence of ligandGang Liu, Cynthia Sprenger, Pin-Jou Wu, et al.
Neoplasia (New York, N.Y.)|September 13, 2013
AR variant ARv567es induces carcinogenesis in a novel transgenic mouse model of prostate cancerGang Liu, Cynthia Sprenger, Shihua Sun, et al.
The Journal of Biological Chemistry|January 1, 2021
Using biochemistry and biophysics to extinguish androgen receptor signaling in prostate cancerIrfan Asangani, Ian A Blair, Gregory Van Duyne, et al.
Nature Communications|November 30, 2016
Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancerChristine Henzler, Yingming Li, Rendong Yang, et al.
The Journal of Clinical Investigation|October 19, 2018
Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancerAdam Sharp, Ilsa Coleman, Wei Yuan, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
European Urology|January 8, 2018
Androgen Receptor Variants and Castration-resistant Prostate Cancer: Looking Back and Looking ForwardTakuma Uo, Cynthia Sprenger
Cell Reports. Medicine|March 4, 2022
Starving lethal prostate cancer by targeting heat shock proteins and glycolytic enzymesStephen R Plymate, Cynthia Sprenger, Michael C Haffner
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Intracrine androgen biosynthesis and drug resistanceTrevor M Penning, Irfan A Asangani, Cynthia Sprenger, et al.
Vitamins and Hormones|September 17, 2023
The androgen receptorGreg Van-Duyne, Ian A Blair, Cynthia Sprenger, et al.
Oncotarget|December 8, 2014
MED1 mediates androgen receptor splice variant induced gene expression in the absence of ligandGang Liu, Cynthia Sprenger, Pin-Jou Wu, et al.
Neoplasia (New York, N.Y.)|September 13, 2013
AR variant ARv567es induces carcinogenesis in a novel transgenic mouse model of prostate cancerGang Liu, Cynthia Sprenger, Shihua Sun, et al.
The Journal of Biological Chemistry|January 1, 2021
Using biochemistry and biophysics to extinguish androgen receptor signaling in prostate cancerIrfan Asangani, Ian A Blair, Gregory Van Duyne, et al.
Nature Communications|November 30, 2016
Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancerChristine Henzler, Yingming Li, Rendong Yang, et al.
The Journal of Clinical Investigation|October 19, 2018
Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancerAdam Sharp, Ilsa Coleman, Wei Yuan, et al.
Pageof 1